Liver transplantation has brought great hope to liver failure patients who came close to death as it was recognized as the most effective therapy of liver disorders since the end of 1983.
However in the East Asian region where there was no practice of brain-dead organ donation despite far more patients with liver diseases, only a very small minority of wealthy people could travel to the U.S., for instance, to receive liver transplantation.
For this reason, living donor liver transplantation was newly introduced as an alternative to brain-dead organ donor liver transplantation. As this new method was performed primarily by Kyoto University, Japan became a mecca of liver transplantation from living donors in the world.
In Korea, Dr. Lee Sung-gyu, of the Department of Liver Transplantation and Hepatobiliary Surgery, first succeeded in pediatric living donor liver transplantation in 1994 and performed living donor liver transplantation using a modified right robe graft for the first time in the world in 1999, raising the survival rate of transplant recipients. In March 2000, AMC’s success of dual living donor liver transplantation from two donors to one recipient gained international attention. In 2004, split liver transplantation from one brain-dead donor to two adult recipients was successfully performed, making AMC a world leader in the field of liver transplantation.
We became the single institution performing the greatest number of living donor liver transplantations in the world. The recipients’ survival rate was very high even though they did not exclude patients in very serious condition. In addition, there was almost no case of complications or death in donors out of more than 2,600 liver transplantations. This is because we have developed a living donor liver transplantation system using various grafts for the safety of donors and are fully prepared for possible complications prior to transplantation.
The AMC Department of Liver Transplantation and Hepatobiliary Surgery’s tireless efforts to save even one life will never end.
Take a look at the treatment of major diseases in your department.
AMC Colorectal Cancer Center improves the prognosis of patients through a multidisciplinary system and integrated treatment to provide best treatment by embracing various opinions of specialists from relevant departments on liver metastasis that often occurs in colorectal cancers, lung metastasis, and locally recurrent cancers such as intractable colorectal cancer.
AMC Liver Cancer Center established a systematic treatment system that allows liver cancer patients to receive optimal treatment in the best medical environment by ▲improving medical treatment of liver cancer patients ▲streamlining a surgery-related process and the use of surgical skills ▲reinforcing cooperation among departments, and ▲promoting a regular meeting and study for multidisciplinary treatment, and carry out high-quality researches.
Around 2,000 first-visit patients with biliary tract and pancreatic cancer visit AMC and more than 800 surgeries for the cancer are performed every year. The number of outpatients has even doubled in five years.
Liver transplantation has first begun in 1963 in the United States, in 1988 in Korea, and in 1992 in AMC. Since then, AMC has first succeeded in living donor liver transplantation in 1994 and has been actively performing even living donor partial liver transplantation in adults since 1997.